Brind.
  1. Anixa Biosciences announced developments regarding its CER-T cancer treatment, collaborating with Cleveland Clinic, at a conference in New York City on September 2, 2025.

Anixa Biosciences and Cleveland Clinic are developing a vaccine portfolio and ovarian cancer immunotherapy program.

1 report, 1 independent Updated Aug 25
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Anixa Biosciences and Cleveland Clinic are developing a vaccine portfolio and ovarian cancer immunotherapy program.

Who's involved

What this event is mainly about
Cleveland Clinic

How it developed

Newest first. Tap a step to see who reported it.
  1. Anixa Biosciences and Cleveland Clinic are collaborating on a vaccine development program, which is now supported by the U.S. Department of Defense.Sub-event
  2. Anixa collaborated with Cleveland Clinic on vaccine development, with Amit Kumar serving as CEO of Anixa.Sub-event
  3. Collaboration between Anixa and Cleveland Clinic focuses on developing vaccine and ovarian cancer treatments.1 source

Keep exploring

Part of

Anixa Biosciences announced developments regarding its CER-T cancer treatment, collaborating with Cleveland Clinic, at a conference in New York City on September 2, 2025. All 1 developments

The entities involved

Coverage

Newest first; wire copies grouped
  • PR NewswireAnixa Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference SAN JOSE, Calif., Aug. 25, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ